Can the CD4+/CD8+ ratio predict the outcome of interferon-alpha therapy for renal cell carcinoma? [electronic resource]
Producer: 19970926Description: 71-7 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- therapeutic use
- CD4-CD8 Ratio
- Carcinoma, Renal Cell -- drug therapy
- Combined Modality Therapy
- Disease-Free Survival
- Female
- Humans
- Immunologic Factors -- therapeutic use
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Kidney Neoplasms -- drug therapy
- Life Tables
- Male
- Middle Aged
- Nephrectomy
- Recombinant Proteins
- Remission Induction
- Survival Analysis
- Treatment Outcome
- Vinblastine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.